Metraipolis › archive › dc_fdf633757d86
Efficacy and safety of maribavir in Japanese patients with post-transplant cytomegalovirus infections: a phase III study — Europe PMC PMID:42283791
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42283791
- DOI
- 10.1007/s12185-[numero omesso]-3
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T12:49:36.819Z
- SHA-256 of the archived text
0813438b00e72a76a0ccc895f9db4ab4ad94bb8a582c0f6542b61d001a36e9d8- Stable URL of this page
https://metraipolis.com/documento/dc_fdf633757d86
How to cite
Efficacy and safety of maribavir in Japanese patients with post-transplant cytomegalovirus infections: a phase III study — Europe PMC PMID:42283791 — Europe PMC (en), https://europepmc.org/article/MED/42283791 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fdf633757d86 (Metraipolis archive dc_fdf633757d86, sha256 0813438b00e72a76a0ccc895f9db4ab4ad94bb8a582c0f6542b61d001a36e9d8)
BibTeX
@misc{dcfdf633757d86,
title = {Efficacy and safety of maribavir in Japanese patients with post-transplant cytomegalovirus infections: a phase III study — Europe PMC PMID:42283791},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42283791},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fdf633757d86; sha256 0813438b00e72a76a0ccc895f9db4ab4ad94bb8a582c0f6542b61d001a36e9d8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42283791. Agents can read the archived copy with the MCP tool read_document.